BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Oct 13, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Results

NasalFent: Preliminary Phase III data

Preliminary data from a double-blind, international Phase III trial (study 043) in 83 patients showed that NasalFent met the primary endpoint of a significant reduction in pain intensity at 30 minutes compared...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >